Asteromorph Opens Wet Lab for AI Biology Research
Asteromorph, a South Korean company developing AI reasoning technology for scientific problems, said on Monday that it has built its own biological laboratory at a bio research complex in Hwaseong and begun full scale operations, The Asia Business Daily reports.
The company plans to combine its AI research with experimental validation in one research system that can generate scientific hypotheses and then test them. The lab will run in vitro experiments on cellular responses and in vivo animal studies to validate biological hypotheses produced by its AI.
Asteromorph says it will use the lab to validate new treatment strategies proposed by AI and to run several therapeutic platform pipelines at once. It aims to rely less on external research facilities, adjust experiment schedules and resources for each project, and turn the data and findings into intellectual property.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from Life Sciences
Nov 2 NAMI joins Common Sense Media youth AI safety standards program Nov 1 Midstream Health Raises $20M to Recover Hospital Payments Oct 31 AI Agent Controls Brain Injection in Live Mouse After Claude Opus Refuses Oct 31 Patient Sues Allegheny Health Network and Highmark Over Abridge AI Recordings Oct 31 OpenAI Releases GPT-Rosalind-6 for Approved Biology ResearchersLife AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Market report
2025 Generative AI in Professional Services Report
Thomson Reuters
This report by Thomson Reuters explores the integration and impact of generative AI technologies, such as ChatGPT and Microsoft Copilot, within the professional services sector. It highlights the growing adoption of GenAI tools across industries like legal, tax, accounting, and government, and discusses the challenges and opportunities these technologies present. The report also examines professionals' perceptions of GenAI and the need for strategic integration to maximize its value.
Read moreYou may also like
Danaher Plans AI Autonomous Lab for Antibody Research
Teragonia Launches Astra Labs for Enterprise AI Workflows
Atlas Bio raises $12.5 million for virtual drug trials
Apodex Offers Free AI Drug Research Services
OpenAI acquires Orchestra Bio to bring AI agents into drug development
Daily AI Brief: the AI news that matters, in your inbox.